Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study.

AD17002 - Advagene Biopharma

http://www.ncbi.nlm.nih.gov/pubmed/39611611

Cheng-Hsun Chiu; Chien-Yu Cheng; Chyi-Liang Chen; Mingi Chang; Peng-Nien Huang; Shin-Ru Shih; Shu-Wei Huang; Ying-Shih Su; Yu-Shen Hsu

Nov 29, 2024